Artificial Intelligence and Machine Learning Technologies to Design Novel Compounds – the result of cooperation between Simulations Plus and the Institute of Medical Biology of the Polish Academy of Sciences.
Simulations Plus – a leading supplier of modeling and simulation software as well as services in the field of pharmaceutical safety and effectiveness, announced the conclusion of a research cooperation agreement with our Institute.
The aim of the cooperation is to design new compounds for the RORγ / RORγT nuclear receptors using the latest artificial intelligence (AI) and machine learning (ML) technology on the ADMET Predictor® software platform. Both Simulations Plus and IBM PAN will make significant intellectual contributions to research, and the intellectual property resulting from the collaboration will be the basis for further development opportunities.
Najnowsze
25/04/2025
Meeting of the Molecular Cell Biology Committee
IBM PAN cordially invites its employees and all interested parties to participate in an open meeting of the Molecular Cell Biology Committee of the Polish Academy of Sciences, which will…
18/01/2024
In quest for new boron carriers for Boron Neutron Capture Therapy (BNCT) of cancer
Boron neutron capture therapy (BNCT) is a promising binary treatment option for certain types of cancer. The BNCT method is based on the high probability of capturing thermal neutrons by…
